Alan Hoberman
Direttore/Membro del Consiglio presso BIOXYTRAN, INC.
Patrimonio netto: 136 272 $ in data 30/04/2024
Posizioni attive di Alan Hoberman
Società | Posizione | Inizio | Fine |
---|---|---|---|
BIOXYTRAN, INC. | Direttore/Membro del Consiglio | 02/11/2018 | - |
Independent Dir/Board Member | 02/11/2018 | - | |
Argus International, Inc.
Argus International, Inc. Industrial MachineryProducer Manufacturing Argus International, Inc. designs and manufactures machinery for the processing of printed circuit boards. Its products include LPI Spray Coating, Thin Film Coating, Hot Air Leveling, and Fusing. The company was founded on March 1, 1965 and is headquartered in Ringoes, NJ. | Amministratore Delegato | - | - |
Presidente | - | - |
Storia della carriera di Alan Hoberman
Precedenti posizioni note di Alan Hoberman
Società | Posizione | Inizio | Fine |
---|---|---|---|
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | Direttore/Membro del Consiglio | - | 03/08/2018 |
Independent Dir/Board Member | - | 03/08/2018 | |
NANOMIX CORPORATION | Direttore/Membro del Consiglio | 25/09/2014 | 15/09/2017 |
Independent Dir/Board Member | 25/09/2014 | 15/09/2017 | |
Argus Research Laboratories, Inc. | Corporate Officer/Principal | 01/01/1991 | 01/01/2013 |
BioXyTran, Inc. /Old/
BioXyTran, Inc. /Old/ Pharmaceuticals: MajorHealth Technology BioXyTran, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of treatments to prevent catastrophic brain damage resulting from hypoxic conditions following brain stroke. The company was founded in 2017 and is headquartered in Newton, MA. | Direttore/Membro del Consiglio | - | - |
Formazione di Alan Hoberman
Pacific Western University | Doctorate Degree |
The University of Arkansas | Graduate Degree |
Drexel University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Posizioni
Director/Board Member | 4 |
Independent Dir/Board Member | 3 |
Chief Executive Officer | 1 |
Settori
Health Technology | 5 |
Consumer Services | 4 |
Producer Manufacturing | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIOXYTRAN, INC. | Health Technology |
Aziende private | 5 |
---|---|
Boston Therapeutics, Inc.
Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
Argus International, Inc.
Argus International, Inc. Industrial MachineryProducer Manufacturing Argus International, Inc. designs and manufactures machinery for the processing of printed circuit boards. Its products include LPI Spray Coating, Thin Film Coating, Hot Air Leveling, and Fusing. The company was founded on March 1, 1965 and is headquartered in Ringoes, NJ. | Producer Manufacturing |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Oxygen Therapy, Inc. is an early stage pharmaceutical company, which engages in the development, manufacture, and commercialization of an innovative platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention. Its product pipeline includes OTI-629, an anti-necrosis drug; and OTI-1011, a resuscitative agent for wound healing applications. The company was founded by David Platt on May 20, 2016 and is headquartered Newton, MA. | Health Technology |
BioXyTran, Inc. /Old/
BioXyTran, Inc. /Old/ Pharmaceuticals: MajorHealth Technology BioXyTran, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of treatments to prevent catastrophic brain damage resulting from hypoxic conditions following brain stroke. The company was founded in 2017 and is headquartered in Newton, MA. | Health Technology |
Argus Research Laboratories, Inc. |
- Borsa valori
- Insiders
- Alan Hoberman
- Esperienza